Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | CES1 | P23141 | 3/20 | 0.54 |
| ▸ | BCHE | P06276 | 2/20 | 0.54 |
| ▸ | CES2 | O00748 | 1/20 | 0.54 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 5/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | IDO1 | P14902 | 3/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | THRB | P10828 | 2/20 | 0.54 |
| ▸ | RECQL | P46063 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | PTPRC | P08575 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Perinaphthenone SCHEMBL29408331 | 1.00 | ALDH1A1 (0.54) | ALDH1A1CES1BCHECES2MCL1 | |
| Perinaphthenone SCHEMBL28873779 | 0.98 | ALDH1A1 (0.52) | ALDH1A1CES1BCHECES2MCL1 | |
| Perinaphthenone SCHEMBL28830245 | 0.98 | ALDH1A1 (0.52) | ALDH1A1CES1BCHECES2MCL1 | |
| Perinaphthenone SCHEMBL31203019 | 0.98 | ALDH1A1 (0.52) | ALDH1A1CES1BCHECES2MCL1 | |
| Perinaphthenone SCHEMBL28852066 | 0.98 | ALDH1A1 (0.52) | ALDH1A1CES1BCHECES2MCL1 | |
| Perinaphthenone SCHEMBL31440761 | 0.98 | ALDH1A1 (0.52) | ALDH1A1CES1BCHECES2MCL1 | |
| Perinaphthenone SCHEMBL27362219 | 0.98 | ALDH1A1 (0.52) | ALDH1A1CES1BCHECES2MCL1 | |
| Perinaphthenone SCHEMBL5339959 | 0.98 | ALDH1A1 (0.52) | ALDH1A1CES1BCHECES2MCL1 | |
| Perinaphthenone SCHEMBL28816358 | 0.96 | ALDH1A1 (0.50) | ALDH1A1CES1BCHECES2MCL1 | |
| Perinaphthenone SCHEMBL27386782 | 0.96 | ALDH1A1 (0.50) | ALDH1A1CES1BCHECES2MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1425 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4007582-B1 | ANTIBIOTICS IN COMBINATION WITH PHOTODYNAMIC THERAPY FOR USE IN A METHOD OF ENHANCING THE ANTIMICROBIAL ACTION OF SYSTEMICALLY ADMINISTERED ANTIBIOTICS | KOITE HEALTH OY (FI) | 2026-05-20 | — | — | EP | claimed |
| US-20260131003-A1 | Method and kit for treating skin infections | KOITE HEALTH OY (FI) | 2026-05-14 | — | — | US | claimed |
| EP-4255560-B1 | KIT FOR TREATMENT OF PATIENTS HAVING DRY MOUTH SYNDROME | KOITE HEALTH OY (FI) | 2026-04-22 | — | — | EP | claimed |
| EP-4719328-A1 | BLEACHING MEDIUM COMPRISING A PHENALENONE | Wella Germany GmbH (DE) | 2026-04-08 | — | — | EP | claimed |
| EP-4695308-A1 | ENGINEERED ANTIBODIES AND USES THEREOF | Invitrogen BioServices India Private Limited (IN) | 2026-02-18 | — | — | EP | claimed |
| US-12521436-B2 | Method and kit for treating skin infections | KOITE HEALTH OY (FI) | 2026-01-13 | — | — | US | claimed |
| EP-4626807-A1 | PACKAGING FOR SMOKING OR AEROSOL GENERATING ARTICLES | JT International SA (CH) | 2025-10-08 | — | — | EP | claimed |
| US-12263349-B2 | Method of treatment of biological surfaces | KOITE HEALTH OY (FI) | 2025-04-01 | — | — | US | claimed |
| WO-2025057225-A1 | ENGINEERED ANTIBODIES AND USES THEREOF | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED (IN) | 2025-03-20 | — | — | WO | claimed |
| US-12161719-B2 | Method of enhancing the antimicrobial action of systemically administered antibiotics | KOITE HEALTH OY (FI) | 2024-12-10 | — | — | US | claimed |
| US-4803157-A | Hydrolyzable fluorescent substrates for phosphatases and analytical use thereof | EASTMAN KODAK COMPANY (US) | 1989-02-07 | — | — | US | claimed |
| US-4797357-A | FLUORESCENT DYES FOR MICROORGANISM DETECTION | EASTMAN KODAK COMPANY (US) | 1989-01-10 | — | — | US | claimed |
| EP-0247847-A2 | Light-stable reducible compounds and analytical compositions, elements and methods utilizing same | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1987-12-02 | — | — | EP | claimed |
| EP-0237548-A1 | NON-DELAMINATING BLENDS OF POLYPHENYLENE ETHER AND ACRYLIC RESIN MODIFIED POLYOLEFINS | GENERAL ELECTRIC COMPANY (US) | 1987-09-23 | — | — | EP | claimed |
| EP-0232129-A2 | Hydrolyzable fluorescent substrates for phosphatases and analytical use thereof | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1987-08-12 | — | — | EP | claimed |
| EP-0231127-A2 | Composition, element and method using polymeric mordants to increase the intensity of rigid fluorescent dyes | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1987-08-05 | — | — | EP | claimed |
| EP-0231125-A2 | Hydrolyzable fluorescent substrates and analytical determinations using same | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1987-08-05 | — | — | EP | claimed |
| WO-1987001380-A1 | NON-DELAMINATING BLENDS OF POLYPHENYLENE ETHER AND ACRYLIC RESIN MODIFIED POLYOLEFINS | GENERAL ELECTRIC COMPANY (US) | 1987-03-12 | — | — | WO | claimed |
| US-4356255-A | Photosensitive members and a process for forming patterns using the same | FUJI PHOTO FILM CO., LTD. (JP) | 1982-10-26 | — | — | US | claimed |
| US-4144284-A | POLYIMIDE PARTICLES DISPERSED IN THERMOPLASTIC POLYMER MATRIX; COEFFICIENT OF FRICTION | RHONE-POULENC INDUSTRIES (FR) | 1979-03-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260131003-A1 | Method and kit for treating skin infections | CUTA, KIT, FLNB | ALDH1A1 2053/4885CES1 4096/4885BCHE 3506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.